EDGEWISE THERAPEUTICS

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. Guided by our approach to targeting the muscle as an organ, we have combined our foundational expertise in muscle biology and small molecule drug discovery to build our proprietary, muscle-focused platform. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases... At Edgewise, we appreciate the life-limiting impact of serious muscle diseases. We are committed to helping people and families living with them by pursuing a new era of muscle-focused medicines with patients at the center... Edgewise Therapeutics, Inc, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe' section below.

Also known as: Edgewise, Edgewise Therapeutics, Inc.

Primary location: Boulder United States